Previous studies have shown that serum spexin levels are significantly lower in patients with T1DM, T2DM, gestational diabetes mellitus, obesity, polycystic ovarian syndrome and nonalcoholic fatty liver disease (6, 11–15). This evidence concerns the gene SPX and metabolic dysfunction-associated steatotic liver disease.